Anti-fibrotic Effects of CXCR4-Targeting i-body AD-114 in Preclinical Models of Pulmonary Fibrosis

Idiopathic pulmonary fibrosis (IPF) is a chronic fibrotic lung disease that is prevalent in individuals >50 years of age, with a median survival of 3–5 years and limited therapeutic options. The disease is characterized by collagen deposition and remodeling of the lung parenchyma in a process tha...

Descripción completa

Detalles Bibliográficos
Autores principales: Griffiths, K., Habiel, D. M., Jaffar, J., Binder, U., Darby, W. G., Hosking, C. G., Skerra, A., Westall, G. P., Hogaboam, C. M., Foley, M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5816662/
https://www.ncbi.nlm.nih.gov/pubmed/29453386
http://dx.doi.org/10.1038/s41598-018-20811-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5816662/
https://www.ncbi.nlm.nih.gov/pubmed/29453386
http://dx.doi.org/10.1038/s41598-018-20811-5

Ejemplares similares